Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11801223 Single vial vaccine formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 29, 2014
Date of Patent
October 31, 2023
Patent Application Number
15108773
Patent Citations
‌
US Patent 6855322 Isolation and purification of P. falciparum merozoite protein-142 vaccine
‌
US Patent 6869607 Vaccine formulations
‌
US Patent 6893820 Detection of methylated CpG rich sequences diagnostic for malignant cells
‌
US Patent 6919078 Antibodies to human tumor necrosis factor receptor TR9
‌
US Patent 6919210 Method for identifying autoimmune disease, method for detecting anti-Reg protein autoantibody and diagnostics for autoimmune disease
‌
US Patent 6929796 Methods to treat undesirable immune responses
‌
US Patent 6932972 Combined vaccine compositions
‌
US Patent 6933123 Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
‌
US Patent 6936255 Vaccine composition comprising herpes simplex virus and human papilloma virus antigens
‌
US Patent 6949246 Compounds and methods for diagnosis of tuberculosis
•••
Patent Inventor Names
Lucien Barnes V.
Steven G. Reed
Ryan M. Kramer
Christopher B. Fox
Thomas Vedvick
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11801223
Patent Primary Examiner
‌
Kyle A Purdy
CPC Code
‌
A61K 47/26
‌
A61K 39/39
‌
A61K 9/10
‌
A61K 9/19

Find more entities like US Patent 11801223 Single vial vaccine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.